Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Amdipharm Mercury Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (43)
Cancellation by sponsor (33)
Prescription medicine registration (2)

Date

2025 (12)
2022 (4)
2021 (1)
2020 (7)
2018 (6)
2017 (24)
2015 (4)
2012 (3)
2011 (2)
2010 (1)
2009 (1)
2007 (3)
2006 (1)
1997 (1)
1995 (1)
1993 (1)
1991 (6)

Search

Sponsor content

78 result(s) found, displaying 21 to 30

CYCLONEX cyclophosphamide 50 mg tablet blister pack (297901)

28 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CYCLONEX cyclophosphamide 50 mg tablet blister pack.
EES erythromycin (as ethyl succinate) 400mg/5mL granules for oral liquid bottle Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
EES 400 erythromycin 400mg (as ethyl succinate) tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
STELAZINE trifluoperazine 1mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
STELAZINE trifluoperazine 2mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
STELAZINE trifluoperazine 5mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
EES erythromycin 200mg/5mL (as ethyl succinate) granules for oral liquid bottle Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
COBAL-B12 INJECTION hydroxocobalamin acetate 1mg/ 1 mL solution for injection ampoule (285067)

24 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for COBAL-B12 INJECTION hydroxocobalamin acetate 1mg/ 1 mL solution for injection ampoule.
TOLERADE 10 imipramine hydrochloride 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2018

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd
TOLERADE 25 imipramine hydrochloride 25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2018

Cancellation by sponsor

Requested by Amdipharm Mercury Australia Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.